Shuttle Pharma Regains Compliance With Nasdaq Minimum Bid Price Requirement
Portfolio Pulse from Benzinga Newsdesk
Shuttle Pharmaceuticals Holdings, Inc. has regained compliance with Nasdaq's Minimum Bid Price Rule by maintaining a stock price above $1.00 for ten consecutive trading days.
August 28, 2024 | 1:02 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Shuttle Pharmaceuticals Holdings, Inc. has successfully regained compliance with Nasdaq's Minimum Bid Price Rule, which requires a stock price above $1.00 for ten consecutive trading days.
Regaining compliance with Nasdaq's Minimum Bid Price Rule is a positive development for Shuttle Pharma, as it avoids potential delisting. This can boost investor confidence and potentially lead to a short-term increase in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100